Chrysamine G

Chrysamine G

SCHEMBL15818022

O=C(O)c1cc(/N=N/c2ccc(-c3ccc(/N=N/c4ccc(O)c(C(=O)O)c4)cc3)cc2)ccc1O.[NaH].[NaH]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.96
KMT2A Q03164 3/20 0.96
TDP1 Q9NUW8 3/20 0.96
APP P05067 1/20 0.96
THRB P10828 1/20 0.96
RECQL P46063 1/20 0.96
BLM P54132 1/20 0.96
BLVRB P30043 2/20 0.82
PDE4A P27815 1/20 0.82
KDR P35968 1/20 0.82
HTT P42858 1/20 0.82
PHLPP2 Q6ZVD8 4/20 0.67
ALDH1A1 P00352 3/20 0.67
PTGS2 P35354 2/20 0.67
CYP2C9 P11712 2/20 0.67
TSHR P16473 2/20 0.67
PTGS1 P23219 1/20 0.67
HSD17B10 Q99714 1/20 0.67
CYP2D6 P10635 1/20 0.67
CYP2C19 P33261 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chrysamine G SCHEMBL7706038 0.98 MEN1 (1.00) MEN1KMT2ATDP1APPTHRB
Chrysamine G SCHEMBL7706036 0.98 MEN1 (1.00) MEN1KMT2ATDP1APPTHRB
Chrysamine G SCHEMBL15818025 0.96 MEN1 (0.96) MEN1KMT2ATDP1APPTHRB
SCHEMBL7711257 0.93 MEN1 (0.90) MEN1KMT2ATDP1APPTHRB
SCHEMBL7711260 0.93 MEN1 (0.90) MEN1KMT2ATDP1APPTHRB
Olsalazine SCHEMBL29769 0.93 MEN1 (0.96) MEN1KMT2ATDP1APPTHRB
Olsalazine SCHEMBL19693100 0.93 MEN1 (0.96) MEN1KMT2ATDP1APPTHRB
Olsalazine SCHEMBL2228872 0.93 MEN1 (0.96) MEN1KMT2ATDP1APPTHRB
Olsalazine SCHEMBL25118 0.91 MEN1 (1.00) MEN1KMT2ATDP1APPTHRB
Olsalazine SCHEMBL29378994 0.91 MEN1 (1.00) MEN1KMT2ATDP1APPTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9808155-B2 Apparatus to detect amyloid in a patient user's retina in a diagnosis, advancement and prognosis of alzheimer's disease, traumatic brain injury, macular degeneration and a plurality of neurodegenerative disorders and ocular diseases NEUROVISION IMAGING LLC (US) 2017-11-07 US claimed
US-20140176908-A1 APPARATUS AND METHOD FOR DETECTING AMYLOID IN A RETINA IN A DIAGNOSIS, ADVANCEMENT, AND PROGNOSING OF ALZHEIMER'S DISEASE, TRAUMATIC BRAIN INJURY, MACULAR DEGENERATION AND A PLURALITY OF NEURODEGENERATIVE DISSORDERS AND OCULAR DISEASES WILDCAT PARTNER HOLDINGS, LP 2014-06-26 US claimed
US-9808155-B2 Apparatus to detect amyloid in a patient user's retina in a diagnosis, advancement and prognosis of alzheimer's disease, traumatic brain injury, macular degeneration and a plurality of neurodegenerative disorders and ocular diseases NEUROVISION IMAGING LLC (US) 2017-11-07 US disclosed
US-20140176908-A1 APPARATUS AND METHOD FOR DETECTING AMYLOID IN A RETINA IN A DIAGNOSIS, ADVANCEMENT, AND PROGNOSING OF ALZHEIMER'S DISEASE, TRAUMATIC BRAIN INJURY, MACULAR DEGENERATION AND A PLURALITY OF NEURODEGENERATIVE DISSORDERS AND OCULAR DISEASES WILDCAT PARTNER HOLDINGS, LP 2014-06-26 US disclosed